Crossmark

A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-021-05361-y

Published Online: 2021-07-15

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sharma, Ambudhar https://orcid.org/0000-0002-6038-3205
Sharma, Charu

Raina, Sujeet

Singh, Balraj

Dadhwal, Devendra Singh

Dogra, Vinay

Gupta, Swatantra

Bhandari, Shyam

Sood, Vivek
License Information

Text and Data Mining valid from 2021-07-15

Version of Record valid from 2021-07-15
More Information

Article History

Received: 28 May 2021

Accepted: 7 June 2021

First Online: 15 July 2021

Declarations

:

: The authors confirm that this trial has received ethical approval from the Dr. Rajendra Prasad Government Medical College Tanda Kangra, Himachal Pradesh 176001 institutional ethical committee as described above. Written informed consent will be obtained from participants before involvement in the trial in the Hindi/English language.

: Written informed consent will be obtained from all participants/subject's legally acceptable representatives before inclusion in the trial for collecting data, analysis, storage, and publishing it.

: Authors declare that they have no competing interests.

Document is current

Any future updates will be listed below